News

Optos will have a strong presence on the Australian ophthalmic events circuit in 2025, providing a key opportunity for eyecare...

A biotech breakthrough with a strong Australian link will be giving about 25,000 people Down Under a little more hope....

The distribution of the D.O.R.C (Dutch Ophthalmic Research Center) product portfolio in Australia and New Zealand will transition to ZEISS...

A Sydney-led, groundbreaking study published in The Ocular Surface journal has provided fresh insights into the quality-of-life burden of dry...

The Australian College of Optometry (ACO) has announced that its Certificate in Ocular Therapeutics (COT) will now run every two...

Australia is likely to be watching with interest as a British company’s “pioneering” approach to cataract surgery is trialled in...

Following the recent reclassification of repeated low-level red-light (RLRL) therapy in China, Eyerising International is hosting an online CPD event...

A gene therapy developed by scientists in the UK has been granted orphan drug designation by the US FDA and...

The Federal Government is deferring the controversial private health insurance reclassification of intravitreal injections for another 12 months and will...

A nonprofit trade association for manufacturers and suppliers of the optical industry in the United States believes that trade tariffs kicked...